Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Simvastatin affects cell motility and actin cytoskeleton distribution of microglia.
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
An Increase in Tolerogenic Dendritic Cell and Natural Regulatory T Cell Numbers during Experimental Autoimmune Encephalomyelitis in Rras-/- Mice Results in Attenuated Disease.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
Baló's Concentric Sclerosis in Multiple Sclerosis.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis (OLTERMS)
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
The diagnosis of multiple sclerosis.
Peripheral tolerance and autoimmunity: lessons from in vivo imaging.
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
Pages
« first
‹ previous
…
266
267
268
269
270
271
272
273
274
…
next ›
last »